Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America 17
Clinical Trials by G7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 18
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Alopecia to Dermatology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Alopecia Therapeutics Clinical Trials 34
Prominent Drugs 35
Latest Clinical Trials News on Alopecia 36
Nov 13, 2019: Cassiopea announces first patient to be enrolled in phase II trial for the treatment of androgenetic alopecia in females with Clascoterone solution 36
Oct 21, 2019: Follicum successfully completes toxicology studies for upcoming FOL-005 Phase IIa clinical trial in patients with hair loss 36
Clinical Trial Profile Snapshots 38
Appendix 269
Abbreviations 269
Definitions 269
Research Methodology 270
Secondary Research 270
About GlobalData 271
Contact Us 271
Source 272
Alopecia Therapeutics, Global, Clinical Trials by Region, 2019* 9
Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 11
Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 12
Alopecia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 13
Alopecia Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 14
Alopecia Therapeutics Clinical Trials, North America, Top Countries, 2019* 15
Alopecia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 16
Alopecia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 17
Proportion of Alopecia to Dermatology Clinical Trials, G7 Countries (%), 2019* 18
Alopecia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Alopecia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Alopecia to Dermatology Clinical Trials, E7 Countries (%), 2019* 21
Alopecia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Alopecia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Alopecia Therapeutics, Global, Clinical Trials by Phase, 2019* 25
Alopecia Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 26
Alopecia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Alopecia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Alopecia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Alopecia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 31
Alopecia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Alopecia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Alopecia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
List of Figures
Alopecia Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Alopecia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Alopecia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Alopecia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 13
Alopecia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 14
Alopecia Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 15
Alopecia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 16
Alopecia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 17
Proportion of Alopecia to Dermatology Clinical Trials, G7 Countries (%), 2019* 18
Alopecia Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Alopecia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Alopecia to Dermatology Clinical Trials, E7 Countries (%), 2019* 21
Alopecia Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 22
Alopecia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Alopecia Therapeutics, Global, Clinical Trials by Phase (%), 2019* 25
Alopecia Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 26
Alopecia Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Alopecia Therapeutics Clinical Trials, Global, by End Point Status, 2019* 29
Alopecia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 30
Alopecia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 31
Alopecia Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Alopecia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Alopecia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 270
【免責事項】
https://www.marketreport.jp/reports-disclaimer